Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Abraxane + cisplatin neoadjuvant chemotherapy followed by cisplatin concurrent with IMRT for locally advanced nasopharyngeal carcinoma
ChiCTR-ONC-12002615Phase 2Completed
- Sponsor
- Sun Yat-sen University Cancer Center
- Start
- Jul 2010
- Modality
- Small Molecules, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of nab-paclitaxel and cisplatin in nasopharyngeal carcinoma (NPC), sponsored by Sun Yat-sen University Cancer Center. Primary endpoint: Objective response rate. Started Jul 2010; status: completed.
02
Drugs
nab-paclitaxelcisplatin
03
Conditions
nasopharyngeal carcinoma (NPC)
Beyond the preview
Go deeper on ChiCTR-ONC-12002615.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-ONC-12002615.